Diagnostic, treatment and aftercare approaches to cocaine abuse

Smith, David Eugene

doi:10.1016/0740-5472(84)90047-3

Cited by 13 publications

(5 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The clinical literature suggests that intermittent cycles of repeated cocaine dosing, that is, binges, followed by abrupt cessation of cocaine use are associated with patterns of withdrawal symptoms and signs (Brower, Maddahian, Blow, & Beresford, 1988; Resnick & Schuyten-Resnick, 1976; Siegel, 1982; Smith, 1984; Trinkoff, Ritter, & Anthony, 1990). Gawin and Kleber (1986) proposed a three-phase model of cocaine abstinence for drug users who self-administer high doses of cocaine in binges based on interviews with cocaine users.…”

mentioning

confidence: 99%

A laboratory model of cocaine withdrawal in humans: Intravenous cocaine.

Foltin¹,

Fischman²

1997

Experimental and Clinical Psychopharmacology

View full text Add to dashboard Cite

Seven adult intravenous (IV) cocaine users completed a protocol investigating changes in behavior after the self-administration of cocaine. During sessions, the participants could self-administer up to 6 doses of IV cocaine (32 mg/70 kg) twice each day. Both 2- and 3-day binge conditions were tested. At 39 hr after the 3-day but not the 2-day binge of cocaine use, total Beck Depression Inventory scores were increased and participants reported increased ratings of Irritable and decreased ratings of I Want Cocaine. Exposure to stimulus cues associated with IV cocaine increased ratings of I Want Cocaine during periods of abstinence after both 2- and 3-day binges and increased ratings of Depressed only after the 3-day binge of cocaine use. The cessation of binge cocaine use produced modest changes in mood and cocaine craving that were related to the length of the binge and varied as a function of time since last cocaine use. Responsiveness to cocaine cues also varied as a function of the length of the previous cocaine binge.

show abstract

mentioning

confidence: 99%

A laboratory model of cocaine withdrawal in humans: Intravenous cocaine.

Foltin¹,

Fischman²

1997

Experimental and Clinical Psychopharmacology

View full text Add to dashboard Cite

show abstract

“…Historically, pharmacological treatment for stimulant use disorders was confined to management of acute symptoms of overdose via beta-blockers, sedatives, or antipsychotics for psychotic episodes (Smith, 1984). Initial approaches to pharmacological treatment of stimulant use disorders per se focused on use of tricyclic antidepressants, either to treat depression when it was perceived as an underlying causal factor for stimulant use (Smith, 1984), or to treat withdrawal symptoms that can resemble depression (Resnick & Resnick, 1984). With growing recognition of the centrality of dopamine (DA) in rewarding effects of stimulants, the focus shifted to both agonist and antagonist strategies involving DA, as reviewed in the following sections.…”

Section: Epidemiology and Prevalencementioning

confidence: 99%

Pharmacological treatment of psychostimulant use disorders.

Schmitz¹,

Wardle²,

Weaver³

et al. 2019

APA Handbook of Psychopharmacology.

View full text Add to dashboard Cite

Implementation of psychopharmacology for the treatment of stimulant use disorders remains a challenge, with no medications specifically approved to treat cocaine or methamphetamine addiction. In the absence of an approved medication, behavioral interventions are the mainstay of treatment. The Tool Kit of Resources provides clinicians with comprehensive reviews of available evidence on pharmacologic treatment strategies. For patients, there are several websites that provide reliable information on understanding and overcoming addiction.

show abstract

“…While some research questions the effectiveness of drug and alcohol education alone (Miller & Hester, 19861, proper timing and targeting of the audience can improve its effectiveness. Mixing assessment procedures with education improves the therapeutic gain and generates information that can be measured and used in later therapeutic contacts (Haddock & Beto, 1988; Smith, 1984).…”

Section: Supportive Therapiesmentioning

confidence: 99%

“…Many times, it is the distress and disruption to the life of a family with a substance abuser that brings about initial contact with the helping professional (Stockwell & Gossop, 1986). The entire family benefits from education regarding the addictive disease and principles of recovery (Smith, 1984), which may be a useful method to introduce the family to treatment. Other research suggests the need to closely assess the family and home life of offenders who are living with their families of origin (Webb, Pratt, Linn, & Carmicheal, 1978).…”

Section: Reeducative Therapiesmentioning

confidence: 99%

Substance Abuse Counseling in Community Corrections: A Primer

Haddock¹

1990

J Addict Offender Couns

View full text Add to dashboard Cite

Substance abuse counseling treatment in community corrections ultimately aims to assist offenders in learning constructive coping skills and restoring social and occupational functioning. A review is discussed of various treatment methods that have survived the tests of empirical scrutiny, clinical experience, and practical financial considerations. In addition, these methods are offered for consideration by community corrections professionals in developing a basic design for outpatient substance abuse treatment programs.

show abstract

Diagnostic, treatment and aftercare approaches to cocaine abuse

Cited by 13 publications

References 4 publications

A laboratory model of cocaine withdrawal in humans: Intravenous cocaine.

A laboratory model of cocaine withdrawal in humans: Intravenous cocaine.

Pharmacological treatment of psychostimulant use disorders.

Substance Abuse Counseling in Community Corrections: A Primer

Contact Info

Product

Resources

About